Linical Co Ltd
TSE:2183
Intrinsic Value
Linical Co., Ltd. engages in pharmaceutical contract research projects providing consulting, monitoring, and quality control services to pharmaceutical companies. [ Read More ]
The intrinsic value of one Linical Co Ltd stock under the Base Case scenario is 980.46 JPY. Compared to the current market price of 390 JPY, Linical Co Ltd is Undervalued by 60%.
Valuation Backtest
Linical Co Ltd
Run backtest to discover the historical profit from buying and selling Linical Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Linical Co Ltd
Current Assets | 12.4B |
Cash & Short-Term Investments | 7.3B |
Receivables | 3.2B |
Other Current Assets | 1.8B |
Non-Current Assets | 5.3B |
Long-Term Investments | 291m |
PP&E | 509.5m |
Intangibles | 3.5B |
Other Non-Current Assets | 1B |
Current Liabilities | 7.2B |
Accrued Liabilities | 470.2m |
Short-Term Debt | 600m |
Other Current Liabilities | 6.1B |
Non-Current Liabilities | 2.6B |
Long-Term Debt | 1.9B |
Other Non-Current Liabilities | 739.4m |
Earnings Waterfall
Linical Co Ltd
Revenue
|
12.5B
JPY
|
Cost of Revenue
|
-8.4B
JPY
|
Gross Profit
|
4.1B
JPY
|
Operating Expenses
|
-3B
JPY
|
Operating Income
|
1.2B
JPY
|
Other Expenses
|
-477.2m
JPY
|
Net Income
|
680.4m
JPY
|
Free Cash Flow Analysis
Linical Co Ltd
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
Linical Co Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
Score
Linical Co Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Linical Co Ltd's solvency score is 73/100. The higher the solvency score, the more solvent the company is.
Score
Linical Co Ltd's solvency score is 73/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Linical Co Ltd
Shareholder Return
Price
Linical Co Ltd
Average Annual Return | -13.48% |
Standard Deviation of Annual Returns | 13.86% |
Max Drawdown | -70% |
Market Capitalization | 8.8B JPY |
Shares Outstanding | 22 586 436 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Linical Co., Ltd. engages in pharmaceutical contract research projects providing consulting, monitoring, and quality control services to pharmaceutical companies. The company is headquartered in Osaka, Osaka-Fu and currently employs 845 full-time employees. The company went IPO on 2008-10-27. The firm operates in two businesses. The CRO segment is engaged in the provision of contract monitoring, quality management and consulting services for phase II and phase III in drug development processes. The Pharmaceutical Sales Support segment is engaged in provision of pharmaceutical sales support for medical institutions in the downstream market.
Contact
IPO
Employees
Officers
The intrinsic value of one Linical Co Ltd stock under the Base Case scenario is 980.46 JPY.
Compared to the current market price of 390 JPY, Linical Co Ltd is Undervalued by 60%.